Petragen, Inc. — Form D/A
Petragen, Inc. of Davie, FL, a company, filed a Form D amendment with the SEC on 2022-02-16. The offering totals $5.0M, of which $1.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-16
- Form: D/A
- Accession: 0001567619-22-004638
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.9M
- Remaining: $3.1M
- Investors: 39
- Date of first sale: 2021-01-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-388495
Issuer
- Name: Petragen, Inc.
- CIK: 0001844157
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 12555 Orange Drive, Suite 236 12555 Orange Drive, Suite 236, Davie, FL, 33330
- Phone: 6173026670
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Kolb | Director | Davie, FL |
| David Kolb | Executive Officer | Davie, FL |
| Demetrios Braddock, MD, PhD | Promoter | Davie, FL |
| Demetrios Braddock, MD, PhD | Related Person | Davie, FL |
| David Kolb | Related Person | Davie, FL |
Other filings by this issuer (2)
More